How to correct a low angle on a Thromboelastography (TEG)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Correcting Low Alpha Angle on Thromboelastography (TEG)

To correct a low alpha angle on TEG, administer fibrinogen replacement using either fibrinogen concentrate (25-50 mg/kg) or cryoprecipitate (1-2 pools), as the alpha angle primarily reflects the rate of fibrin formation and is most strongly influenced by fibrinogen levels. 1, 2

Understanding Alpha Angle on TEG

  • Alpha angle represents the speed of clot formation and is primarily influenced by fibrinogen concentration and function 1
  • Normal alpha angle values typically range from 53-72 degrees, with lower values indicating slower clot formation 1
  • Decreased alpha angle suggests impaired fibrinogen function or deficiency 1

Diagnostic Approach

  • Confirm the low alpha angle finding with a functional fibrinogen TEG if available 2
  • Consider conventional laboratory testing for fibrinogen levels to guide replacement therapy 3
  • Check for concurrent abnormalities in other TEG parameters that may indicate additional coagulation issues 1

Treatment Algorithm

  • For mild to moderate reduction in alpha angle:

    • Administer fibrinogen concentrate (first choice) at 25-50 mg/kg 2, 3
    • Alternative: 1 pool of cryoprecipitate (contains approximately 2g of fibrinogen) 2
  • For severe reduction in alpha angle:

    • Administer fibrinogen concentrate at 50-60 mg/kg 2
    • Alternative: 2 pools of cryoprecipitate 2
  • Target fibrinogen level of at least 1.5-2.0 g/L in bleeding patients 2, 3

  • Higher fibrinogen targets (>2.0 g/L) may be needed in obstetric hemorrhage 3

Monitoring Response

  • Repeat TEG 15-30 minutes after intervention to assess response 3
  • Target alpha angle normalization (typically >53 degrees) 1
  • If response is inadequate, consider additional fibrinogen replacement 2

Special Considerations

Liver Disease

  • Patients with cirrhosis often have rebalanced hemostasis despite abnormal conventional coagulation tests 4
  • TEG-guided blood product transfusion has been shown to decrease transfusion requirements compared to standard care in liver disease 2
  • Target fibrinogen levels may need to be higher (≥2.0 g/L) in liver disease patients 2

Trauma

  • In trauma patients with bleeding, TEG-guided resuscitation has demonstrated improved outcomes compared to conventional testing 5
  • For trauma patients, consider a threshold of alpha angle <67 degrees for fibrinogen replacement 5

Pitfalls to Avoid

  • Anemia can paradoxically show hypercoagulable TEG results due to decreased blood viscosity, potentially masking coagulopathy 4
  • High variability of TEG measurements (coefficients of variance ranging from 7.1% to 39.9%) necessitates proper training and regular calibration 4
  • Results vary between devices and are not interchangeable between TEG and ROTEM systems 4
  • TEG is performed at 37°C and cannot assess effects of hypothermia on coagulation 4
  • Do not rely solely on conventional coagulation tests (PT, aPTT) as they may not correlate well with TEG parameters 4

Efficacy of TEG-Guided Therapy

  • TEG-guided transfusion strategies have been shown to result in fewer blood transfusions compared to conventional coagulation test-guided strategies 2, 6
  • Goal-directed therapy using TEG parameters allows for more targeted correction of specific coagulation defects 2
  • In trauma patients, TEG-guided resuscitation has demonstrated lower mortality at 24 hours and 30 days compared to conventional testing 2

References

Guideline

Interpreting Thromboelastography (TEG) Parameters and Clinical Applications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Correcting Low Citrated Functional Fibrinogen on Thromboelastography

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Correcting Low Maximum Amplitude on Thromboelastography

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.